ESSA Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ESSA Pharma generated cash of -$22,716,199, which is less than the previous year. Cash used in financing activities reached the amount of $925,510 last year. Net change in cash is therefore $70,007,625.
Cash Flow
| 2015 | -12.30M | -158.02K | 11.07M |
|---|---|---|---|
| 2016 | -15.30M | -9.98K | 22.74M |
| 2017 | -17.35M | 0 | 12.32M |
| 2018 | -10.21M | -201.39K | 21.31M |
| 2019 | -12.24M | -45.50K | 50.81M |
| 2020 | -16.98M | -21.73M | 41.77M |
| 2021 | -25.41M | -35.01M | 141.99M |
| 2022 | -28.70M | -52.34M | 252.73K |
| 2023 | -19.78M | -3.52M | -68.15K |
| 2024 | -22.71M | 91.78M | 925.51K |
EPIX Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 33.70M | 57.07M | 137.82M | 56.32M | 53.32M | 14.82M | 3.95M | 8.98M | 1.57M | 3.08M |
Operating activities | ||||||||||
Net income | -28.54M | -26.58M | -35.10M | -36.80M | -23.44M | -10.44M | -11.62M | -4.72M | -13.13M | -8.56M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 118.49K | 121.78K | 109.46K | 110.32K | 18.29K | 34.48K | 46.14K | 66.18K | 39.09K |
Stock-based compensation expense | 6.53M | 5.00M | 7.88K | 9.47M | 7.52M | 1.14K | 0 | 758.92K | 1.24M | 1.29M |
| Deferred income tax benefit | 6.53M | 5.00M | 7.88K | 9.47M | 7.52M | 1.14K | 0 | 758.92K | 1.24M | 1.29M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -128.84K | 482.80K | -157.57K | 89.93K | -59.66K | 0 | -14.64K | 0 | -11.69K |
Inventories | 0 | 0 | 0 | 157.57K | -89.93K | 59.66K | 0 | 0 | 0 | -6.00M |
Accounts payable | 0 | 0 | 0 | 2.66M | -46.35K | -1.01M | -1.12M | -1.86M | 0 | 2.11M |
Cash generated by operating activities | -22.71M | -19.78M | -28.70M | -25.41M | -16.98M | -12.24M | -10.21M | -17.35M | -15.30M | -12.30M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -365.20M | -296.01M | -57.02M | -22.01M | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.98K | -158.02K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | -246.90K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 91.78M | -3.52M | -52.34M | -35.01M | -21.73M | -45.50K | -201.39K | 0 | -9.98K | -158.02K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 68.70K | 386.75K | 149.99M | 48.99M | 36M | 26.04M | 2.93K | 19.99M | 13.20M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -136.86K | -134.02K | -100.28K | -4.00M | -2.80M | -1.99M | 8M | 0 | 0 |
Cash used in financing activities | 925.51K | -68.15K | 252.73K | 141.99M | 41.77M | 50.81M | 21.31M | 12.32M | 22.74M | 11.07M |
Net Change In Cash | 70.00M | -23.37M | -80.74M | 81.50M | 2.99M | 38.49M | 10.87M | -5.02M | 7.40M | -1.51M |
Cash at end of period | 103.70M | 33.70M | 57.07M | 137.82M | 56.32M | 53.32M | 14.82M | 3.95M | 8.98M | 1.56M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |